Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia

Código QR

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia

Desye Gebrie,1,2 Tsegahun Manyazewal,2 Dawit A Ejigu,3 Eyasu Makonnen2,4 1School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia; 2Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gebrie D, Manyazewal T, Ejigu DA, Makonnen E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	glycemic control cardiovascular diseases type 2 diabetes mellitus metformin insulin sulfonylurea glycated hemoglobin a1c (hba1c) Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/447e5594f09c45049bdd8c72ab109508
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus
por: Bukhsh A, et al.
Publicado: (2019)

The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus
por: Jie Qian, et al.
Publicado: (2021)

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
por: Hassoun AAK, et al.
Publicado: (2016)

Epidemiology of diabetes mellitus and prognosis of its prevalence in the Russian Federation
por: Yury Ivanovich Suntsov, et al.
Publicado: (2011)

Effect of Metformin or Chinese Herbal Formula in Patients with Type 2 Diabetes Mellitus and Hyperlipidemia: A Reassessment
por: Venu Gopal Jonnalagadda, et al.
Publicado: (2018)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
por: Kunavisarut T, et al.
Publicado: (2019)

Glucoherb versus metformin on glycemic markers and glycosylated hemoglobin in prediabetes patients; a clinical trial study
por: Iman Izadi, et al.
Publicado: (2021)

Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study
por: Chen P, et al.
Publicado: (2020)

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Soon-Jib Yoo, et al.
Publicado: (2021)

Prognostic Value of Glycated Hemoglobin in Frail Older Diabetic Patients With Hip Fracture
por: Simone Paterni, et al.
Publicado: (2021)

Blood Levels of Glycated Hemoglobin, D-Dimer, and Fibrinogen in Diabetic Retinopathy
por: Zhao H, et al.
Publicado: (2021)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

Prevalence and prevention of rheumatologic manifestations and their relationship with blood glucose control in patients with type ii diabetes
por: Zahra Kamiab, et al.
Publicado: (2021)

Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MB
por: Alexander Sergeevich Ametov, et al.
Publicado: (2009)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
por: Natalya Vladislavovna Zaytseva, et al.
Publicado: (2015)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
por: Cai X, et al.
Publicado: (2020)

Optimizing glycemic control in type 2 diabetic patients through the use of a low-carbohydrate, high-fat, ketogenic diet: a review of two patients in primary care
por: Rallis S
Publicado: (2019)

Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials
por: Desye Gebrie, et al.
Publicado: (2021)

Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial
por: María Molina-Vega, et al.
Publicado: (2022)

Effectiveness of a WeChat Combined Continuous Flash Glucose Monitoring System on Glycemic Control in Juvenile Type 1 Diabetes Mellitus Management: Randomized Controlled Trial
por: Xu Y, et al.
Publicado: (2021)

The comparison of two measuring methods of Glycolated hemoglobin in fasting and non-fasting conditions
por: H Alaoddolei, et al.
Publicado: (2000)

Efficacy and safety of evogliptin versus sitagliptin as add on to metformin alone in a combined russian-korean population. Evo-combi trial
por: Alina Y. Babenko, et al.
Publicado: (2018)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
por: I Yu Demidova, et al.
Publicado: (2009)

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
por: Natthida Sriboonvorakul, et al.
Publicado: (2021)

Unexpected Detection of Abnormal Hemoglobin Variants During Routine HbA1c Analysis by HPLC Technique: Challenges and Opportunities in HbA1c Testing
por: Neelam Narsingrao Sreedevi, et al.
Publicado: (2021)

Poor Glycemic Control and the Contributing Factors Among Type 2 Diabetes Mellitus Patients Attending Outpatient Diabetes Clinic at Mbarara Regional Referral Hospital, Uganda
por: Patrick NB, et al.
Publicado: (2021)

Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)
por: Sergey V. Kakorin, et al.
Publicado: (2016)

Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study
por: Alzahrani SH, et al.
Publicado: (2019)

Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway
por: Yi Xiao, et al.
Publicado: (2020)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

Self-Monitoring of Blood Glucose and Hypoglycemia Association During Fasting in Ramadan Among Patients with Diabetes
por: Mansouri D, et al.
Publicado: (2020)

Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study)
por: N. A. Demidov, et al.
Publicado: (2021)

Relation between Iron Status and Hemoglobin A1c in Children with Type-1 Diabetes Mellitus
por: Fatma El Nezely, et al.
Publicado: (2021)

Diabetes and elevated preoperative HbA1c level as risk factors for postoperative delirium after cardiac surgery: an observational cohort study
por: Kotfis K, et al.
Publicado: (2019)

Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
por: Christoph Sinning, et al.
Publicado: (2021)

Metformin and Malignant Tumors: Not Over the Hill
por: Leng W, et al.
Publicado: (2021)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
por: Elena Efimovna Petryaykina, et al.
Publicado: (2009)

A COMPARATIVE STUDY OF HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) AND GLYCEMIC MARKERS IN TYPE 2 DIABETES MELLITUS
por: Shehar Bano Imran, et al.
Publicado: (2021)

Assessment of Serum Vitamin B12 and Folate Levels and Macrocytosis in Patients with Type 2 Diabetes Mellitus on Metformin Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study
por: Wale Tesega W, et al.
Publicado: (2021)

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019
por: Marina V. Shestakova, et al.
Publicado: (2020)